A case of vitamin D hydroxylation-deficient rickets type 1A caused by 2 novel pathogenic variants in CYP27B1 gene
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Vitamin D hydroxylation-deficient rickets type 1A (VDDR1A, OMIM 264700) is a rare autosomal recessive inherited disorder. Pathogenic variants in the CYP27B1 gene lead to loss of 1α-hydroxylase activity. We report the case of a 22-month-old toddler who presented with growth retardation and delayed development. The patient exhibited the typical laboratory findings of VDDR1A, including hypocalcemia (calcium: 5.2 mg/dL), elevated serum level of alkaline phosphatase (2,600 U/L), elevated serum level of intact-parathyroid hormone (238 pg/mL), low 1,25(OH)2D3 level (11.2 pg/mL), and normal 25(OH)D3 level (40.7 ng/mL). His height and weight were 76.5 cm and 9.5 kg, respectively (both <3rd percentile). The Bayley Scales of Infant and Toddler Development II indicated significantly delayed development (mental development index <50, psychomotor development index <50). The patient was a compound heterozygous for two novel pathogenic variants in the CYP27B1 gene: c.57_69del (p.Glu20Profs*2) and c.171dupG (p.Leu58Alafs*275), inherited from his mother and father, respectively. The patient showed remarkable improvement after treatment with calcitriol and calcium carbonate.
Abstract
Vitamin D hydroxylation-deficient rickets type 1A (VDDR1A, OMIM 264700) is a rare autosomal recessive inherited disorder. Pathogenic variants in the CYP27B1 gene lead to loss of 1α-hydroxylase activity. We report the case of a 22-month-old toddler who presented with growth retardation and delayed development. The patient exhibited the typical laboratory findings of VDDR1A, including hypocalcemia (calcium: 5.2 mg/dL), elevated serum level of alkaline phosphatase (2,600 U/L), elevated serum level of intact-parathyroid hormone (238 pg/mL), low 1,25(OH)2D3 level (11.2 pg/mL), and normal 25(OH)D3 level (40.7 ng/mL). His height and weight were 76.5 cm and 9.5 kg, respectively (both <3rd percentile). The Bayley Scales of Infant and Toddler Development II indicated significantly delayed development (mental development index <50, psychomotor development index <50). The patient was a compound heterozygous for two novel pathogenic variants in the CYP27B1 gene: c.57_69del (p.Glu20Profs*2) and c.171dupG (p.Leu58Alafs*275), inherited from his mother and father, respectively. The patient showed remarkable improvement after treatment with calcitriol and calcium carbonate.
참고문헌 (19)
- Elder CJ, "Rickets", Lancet, 383, pp.1665~1676 (2014)
- Miller WL, "Genetic disorders of Vitamin D biosynthesis and degradation", J Steroid Biochem Mol Biol, 165(Pt A), pp.101~108 (2017)
- Fu GK, "Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1", Mol Endocrinol, 11, pp.1961~1970 (1997)
- Fu GK, "Complete structure of the human gene for the vitamin D 1alpha-hydroxylase, P450c1alpha", DNA Cell Biol, 16, pp.1499~1507 (1997)
- St-Arnaud R, "The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR)disease locus", J Bone Miner Res, 12, pp.1552~1559 (1997)
- Kitanaka S, "Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets", N Engl J Med, 338, pp.653~661 (1998)
- Creo AL, "Nutritional rickets around the world: an update", Paediatr Int Child Health, 37, pp.84~98 (2017)
- De Braekeleer M, "Population genetics of vitamin D-dependent rickets in northeastern Quebec", Ann Hum Genet, 55, pp.283~290 (1991)
- Wang JT, "Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families", Am J Hum Genet, 63, pp.1694~1702 (1998)
- Kim CJ, "Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency", J Clin Endocrinol Metab, 92, pp.3177~3182 (2007)
- 조자향, "Long-term clinical outcome and the identification of homozygous CYP27B1 gene mutations in a patient with vitamin D hydroxylation-deficient rickets type 1A", Annals of Pediatric Endocrinology & Metabolism, 21(3), pp.169~173 (2016), 대한소아내분비학회
- Durmaz E, "Clinical and genetic analysis of patients with vitamin D-dependent rickets type 1A", Clin Endocrinol (Oxf), 77, pp.363~369 (2012)
- Tahir S, "Genotype and phenotype characteristics in 22patients with vitamin D-dependent rickets type I", Horm Res Paediatr, 85, pp.309~317 (2016)
- Acar S, "Genetic causes of rickets", J Clin Res Pediatr Endocrinol, 9(Suppl 2), pp.88~105 (2017)
- Wang X, "Novel gene mutations in patients with 1alpha-hydroxylase deficiency that confer partial enzyme activity in vitro", J Clin Endocrinol Metab, 87, pp.2424~2430 (2002)
- Giannakopoulos A, "A case of vitamin-D-dependent rickets type 1A with normal 1,25-dihydroxyvitamin D caused by two novel mutations of the CYP27B1 gene", Horm Res Paediatr, 87, pp.58~63 (2017)
- Alzahrani AS, "A novel G102E mutation of CYP27B1in a large family with vitamin D-dependent rickets type 1", J Clin Endocrinol Metab, 95, pp.4176~4183 (2010)
- Edouard T, "Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol", J Clin Endocrinol Metab, 96, pp.82~89 (2011)
- Baştuğ F, "Urolithiasis in infants: evaluation of risk factors", World J Urol, 31, pp.1117~1122 (2013)